Artificial intelligence (AI) is steadily reshaping healthcare from all sides, introducing technologies we wouldn’t have thought possible five or 10 years ago.
It’s happening in the clinic (see HealthTap’s Doctor A.I.), it’s happening in diagnostics (see IBM Watson), and now it’s moving into earlier-stage drug discovery with Palo Alto, California-based twoXAR.
